HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.

Abstract
A controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was performed in a pair of 7 1/2 year-old monozygotic twins, with Duchenne muscular dystrophy (DMD). The rationale for this trial was based on a patient (reported previously) affected simultaneously with DMD and growth hormone (GH) deficiency, who is showing a benign course of the dystrophic process and is still walking at 18 years. One of the twins received 2 mg of mazindol daily, while the other received a placebo. The assessment, repeated every 2 months, included weight and height measurements, functional and motor ability tests, ergometry and determinations of serum enzymes and GH levels. After one year of trial the code was broken and it was seen that the twin under placebo treatment was strikingly worse than his brother, the progression of whose condition was practically arrested. These results strongly suggest that treatment with a GH inhibitor is beneficial for DMD patients.
AuthorsM Zatz, R T Betti, O Frota-Pessoa
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 24 Issue 3 Pg. 549-66 (Jul 1986) ISSN: 0148-7299 [Print] United States
PMID3524231 (Publication Type: Case Reports, Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Indoles
  • Growth Hormone
  • Mazindol
Topics
  • Body Height
  • Body Weight
  • Child
  • Clinical Trials as Topic
  • Diseases in Twins
  • Double-Blind Method
  • Growth Hormone (antagonists & inhibitors)
  • Humans
  • Indoles (therapeutic use)
  • Male
  • Mazindol (therapeutic use)
  • Muscles (physiopathology)
  • Muscular Dystrophies (drug therapy, genetics, physiopathology)
  • Twins, Monozygotic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: